Literature DB >> 8432327

Sialic acid content and surface hydrophobicity of group B streptococci.

L A Teixeira1, A M Figueiredo, B T Ferreira, V M Alves, P E Nagao, C S Alviano, J Angluster, F C Silva-Filho, L C Benchetrit.   

Abstract

The sialic acid content and the cell-surface hydrophobicity index of 40 group B streptococci (GBS) strains were assessed. GBS isolated from invasive infections (virulent strains) presented an increased level of sialic acid content (1.4%) when compared with GBS isolated from asymptomatic patients (0.53%). Treatment of GBS strain 85634 with neuraminidase resulted in a decrease (about 25%) in the net negative surface charge as assessed by cell electrophoresis. This finding suggests that sialic acid residues are important anionogenic groups exposed on GBS cell surface. N-acetylneuraminic acid was the only sialic acid derivative characterized in the strain 85634 as evaluated by gas-liquid chromatography. GBS from different serotypes presented a hydrophobic index mean value of 0.9. Even though the sialic acid contributed effectively to the negative charge on GBS cell surface, no difference was observed in the hydrophobic index when virulent and avirulent strains were compared.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432327      PMCID: PMC2271973          DOI: 10.1017/s0950268800050718

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  20 in total

1.  The sialic acids. XI. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides.

Authors:  G W Jourdian; L Dean; S Roseman
Journal:  J Biol Chem       Date:  1971-01-25       Impact factor: 5.157

2.  Sialoglycoproteins and sialoglycolipids contribute to the negative surface charge of epimastigote and trypomastigote forms of Trypanosoma cruzi.

Authors:  T Souto-Padrón; W de Souza
Journal:  Biochim Biophys Acta       Date:  1985-03-28

3.  Assessment of the virulence factors of group B streptococci: correlation with sialic acid content.

Authors:  A O Shigeoka; N S Rote; J I Santos; H R Hill
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

4.  The nature of sialic acids in human lymphocytes.

Authors:  J P Kamerling; J Makovitzky; R Schauer; J F Vliegenthart; M Wember
Journal:  Biochim Biophys Acta       Date:  1982-02-02

5.  Identification of the sialic acids from the egg jelly coat of the sea urchin Pseudocentrotus depressus (Okayama).

Authors:  J P Kamerling; R Schauer; J F Vliegenthart; K Hotta
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1980-10

Review 6.  Group B streptococcal vaccines.

Authors:  C J Baker; D L Kasper
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

7.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.

Authors:  J M Musser; S J Mattingly; R Quentin; A Goudeau; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

8.  Teichoic acids of Streptococcus agalactiae: chemistry, cytotoxicity, and effect on bacterial adherence to human cells in tissue culture.

Authors:  J C Goldschmidt; C Panos
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

9.  Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells.

Authors:  T J Nealon; S J Mattingly
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

10.  Contributions of lipids and proteins to the surface charge of membranes. An electron microscopy study with cationized and anionized ferritin.

Authors:  R W Burry; J G Wood
Journal:  J Cell Biol       Date:  1979-09       Impact factor: 10.539

View more
  1 in total

1.  Antifungal Properties of Crude Extracts, Fractions, and Purified Compounds from Bark of Curatella americana L. (Dilleniaceae) against Candida Species.

Authors:  Cleyton Eduardo Mendes de Toledo; Patrícia Regina Santos; João Carlos Palazzo de Mello; Benedito Prado Dias Filho; Celso Vataru Nakamura; Tânia Ueda-Nakamura
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-11       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.